Biotechnology Market Size to touch USD 1,345.0 Billion by 2030
Acumen Research and Consulting has announced the addition of the “Biotechnology Market” report to their offering.
The Biotechnology Market Industry Report 2030 is an in depth study analyzing the current state of the Biotechnology Market. It provides brief overview of the market focusing on definitions, market segmentation, end-use applications and industry chain analysis. The study on Biotechnology Market provides analysis of China market covering the industry trends, recent developments in the market and competitive landscape. Competitive analysis includes competitive information of leading players in China market, their company profiles, product portfolio, capacity, production, and company financials. In addition, report also provides upstream raw material analysis and downstream demand analysis along with the key development trends and sales channel analysis. Research study on Biotechnology Market also discusses the opportunity areas for investors.
Download Sample Report Copy From Here:https://www.acumenresearchandconsulting.com/request-sample/2591
The report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
Market Players as below:
Some of the top biotechnology market companies offered in the professional report include AstraZeneca plc, Gilead Sciences, Inc., Celgene Corporation, Biogen Inc., Abbott Laboratories, Amgen Inc., Novo Nordisk A/S, Merck & Co., Inc., Johnson & Johnson Services, Inc., and Novartis AG.
Market Segmentation:
Biotechnology Market By Technology
- Nanobiotechnology
- Tissue Engineering and Regeneration
- DNA Sequencing
- Cell-based Assays
- Fermentation
- PCR Technology
- Chromatography
- Others
Biotechnology Market By Application
- Health
- Food & Agriculture
- Natural Resources & Environment
- Industrial Processing
- Bioinformatics
- Others
Table Of Contents:
CHAPTER 1. Industry Overview of Biotechnology Market
1.1. Definition and Scope
1.1.1. Definition of Biotechnology
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Biotechnology Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Biotechnology Market By Technology
1.2.3. Biotechnology Market By Application
1.2.4. Biotechnology Market By Region
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Biotechnology Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Biotechnology Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Regulatory Compliance
3.9. Competitive Landscape, 2021
3.9.1. Player Positioning Analysis
3.9.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Biotechnology Market By Technology
4.1. Introduction
4.2. Biotechnology Revenue By Technology
4.2.1. Biotechnology Revenue (USD Billion) and Forecast, By Technology, 2018-2030
4.2.2. Nanobiotechnology
4.2.2.1. Nanobiotechnology Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
4.2.3. Tissue Engineering and Regeneration
4.2.3.1. Tissue Engineering and Regeneration Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
4.2.4. DNA Sequencing
4.2.4.1. DNA Sequencing Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
4.2.5. Cell-based Assays
4.2.5.1. Cell-based Assays Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
4.2.6. Fermentation
4.2.6.1. Fermentation Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
4.2.7. PCR Technology
4.2.7.1. PCR Technology Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
4.2.8. Chromatography
4.2.8.1. Chromatography Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
4.2.9. Others
4.2.9.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
CHAPTER 5. Biotechnology Market By Application
5.1. Introduction
5.2. Biotechnology Revenue By Application
5.2.1. Biotechnology Revenue (USD Billion) and Forecast, By Application, 2018-2030
5.2.2. Health
5.2.2.1. Health Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
5.2.3. Food & Agriculture
5.2.3.1. Food & Agriculture Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
5.2.4. Natural Resources & Environment
5.2.4.1. Natural Resources & Environment Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
5.2.5. Industrial Processing
5.2.5.1. Industrial Processing Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
5.2.6. Bioinformatics
5.2.6.1. Bioinformatics Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
5.2.7. Others
5.2.7.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
CHAPTER 6. North America Biotechnology Market By Country
6.1. North America Biotechnology Market Overview
6.2. U.S.
6.2.1. U.S. Biotechnology Revenue (USD Billion) and Forecast By Technology, 2018-2030
6.2.2. U.S. Biotechnology Revenue (USD Billion) and Forecast By Application, 2018-2030
6.3. Canada
6.3.1. Canada Biotechnology Revenue (USD Billion) and Forecast By Technology, 2018-2030
6.3.2. Canada Biotechnology Revenue (USD Billion) and Forecast By Application, 2018-2030
6.4. North America PEST Analysis
CHAPTER 7. Europe Biotechnology Market By Country
7.1. Europe Biotechnology Market Overview
7.2. U.K.
7.2.1. U.K. Biotechnology Revenue (USD Billion) and Forecast By Technology, 2018-2030
7.2.2. U.K. Biotechnology Revenue (USD Billion) and Forecast By Application, 2018-2030
7.3. Germany
7.3.1. Germany Biotechnology Revenue (USD Billion) and Forecast By Technology, 2018-2030
7.3.2. Germany Biotechnology Revenue (USD Billion) and Forecast By Application, 2018-2030
France
7.3.3. France Biotechnology Revenue (USD Billion) and Forecast By Technology, 2018-2030
7.3.4. France Biotechnology Revenue (USD Billion) and Forecast By Application, 2018-2030
7.4. Spain
7.4.1. Spain Biotechnology Revenue (USD Billion) and Forecast By Technology, 2018-2030
7.4.2. Spain Biotechnology Revenue (USD Billion) and Forecast By Application, 2018-2030
7.5. Rest of Europe
7.5.1. Rest of Europe Biotechnology Revenue (USD Billion) and Forecast By Technology, 2018-2030
7.5.2. Rest of Europe Biotechnology Revenue (USD Billion) and Forecast By Application, 2018-2030
7.6. Europe PEST Analysis
CHAPTER 8. Asia Pacific Biotechnology Market By Country
8.1. Asia Pacific Biotechnology Market Overview
8.2. China
8.2.1. China Biotechnology Revenue (USD Billion) and Forecast By Technology, 2018-2030
8.2.2. China Biotechnology Revenue (USD Billion) and Forecast By Application, 2018-2030
8.3. Japan
8.3.1. Japan Biotechnology Revenue (USD Billion) and Forecast By Technology, 2018-2030
8.3.2. Japan Biotechnology Revenue (USD Billion) and Forecast By Application, 2018-2030
8.4. India
8.4.1. India Biotechnology Revenue (USD Billion) and Forecast By Technology, 2018-2030
8.4.2. India Biotechnology Revenue (USD Billion) and Forecast By Application, 2018-2030
8.5. Australia
8.5.1. Australia Biotechnology Revenue (USD Billion) and Forecast By Technology, 2018-2030
8.5.2. Australia Biotechnology Revenue (USD Billion) and Forecast By Application, 2018-2030
8.6. South Korea
8.6.1. South Korea Biotechnology Revenue (USD Billion) and Forecast By Technology, 2018-2030
8.6.2. South Korea Biotechnology Revenue (USD Billion) and Forecast By Application, 2018-2030
8.7. Rest of Asia-Pacific
8.7.1. Rest of Asia-Pacific Biotechnology Revenue (USD Billion) and Forecast By Technology, 2018-2030
8.7.2. Rest of Asia-Pacific Biotechnology Revenue (USD Billion) and Forecast By Application, 2018-2030
8.8. Asia Pacific PEST Analysis
CHAPTER 9. Latin America Biotechnology Market By Country
9.1. Latin America Biotechnology Market Overview
9.2. Brazil
9.2.1. Brazil Biotechnology Revenue (USD Billion) and Forecast By Technology, 2018-2030
9.2.2. Brazil Biotechnology Revenue (USD Billion) and Forecast By Application, 2018-2030
9.3. Mexico
9.3.1. Mexico Biotechnology Revenue (USD Billion) and Forecast By Technology, 2018-2030
9.3.2. Mexico Biotechnology Revenue (USD Billion) and Forecast By Application, 2018-2030
9.4. Rest of Latin America
9.4.1. Rest of Latin America Biotechnology Revenue (USD Billion) and Forecast By Technology, 2018-2030
9.4.2. Rest of Latin America Biotechnology Revenue (USD Billion) and Forecast By Application, 2018-2030
9.5. Latin America PEST Analysis
CHAPTER 10. Middle East & Africa Biotechnology Market By Country
10.1. Middle East & Africa Biotechnology Market Overview
10.2. GCC
10.2.1. GCC Biotechnology Revenue (USD Billion) and Forecast By Technology, 2018-2030
10.2.2. GCC Biotechnology Revenue (USD Billion) and Forecast By Application, 2018-2030
10.3. South Africa
10.3.1. South Africa Biotechnology Revenue (USD Billion) and Forecast By Technology, 2018-2030
10.3.2. South Africa Biotechnology Revenue (USD Billion) and Forecast By Application, 2018-2030
10.4. Rest of Middle East & Africa
10.4.1. Rest of Middle East & Africa Biotechnology Revenue (USD Billion) and Forecast By Technology, 2018-2030
10.4.2. Rest of Middle East & Africa Biotechnology Revenue (USD Billion) and Forecast By Application, 2018-2030
10.5. Middle East & Africa PEST Analysis
CHAPTER 11. Player Analysis Of Biotechnology Market
11.1. Biotechnology Market Company Share Analysis
11.2. Competition Matrix
11.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
11.2.2. New Product Launches and Product Enhancements
11.2.3. Mergers And Acquisition In Global Biotechnology Market
11.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 12. Company Profile
12.1. AstraZeneca plc
12.1.1. Company Snapshot
12.1.2. Business Overview
12.1.3. Financial Overview
12.1.3.1. Revenue (USD Billion), 2021
12.1.3.2. AstraZeneca plc 2021 Biotechnology Business Regional Distribution
12.1.4. Product/Service and Specification
12.1.5. Recent Developments & Business Strategy
12.2. Gilead Sciences, Inc.
12.3. Celgene Corporation
12.4. Biogen Inc.
12.5. Abbott Laboratories
12.6. Amgen Inc.
12.7. Novo Nordisk A/S
12.8. Merck & Co., Inc.
12.9. Johnson & Johnson Services, Inc.
12.10. Novartis AG
Ask Query Here: Richard@acumenresearchandconsulting.com or sales@acumenresearchandconsulting.com
To Purchase this Premium Report@https://www.acumenresearchandconsulting.com/buy-now/0/2591
About Us:
Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.
